Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation: a pharmacological and SPECT study.

Linazasoro G, Van Blercom N, Bergaretxe A, Iñaki FM, Laborda E, Ruiz Ortega JA.

Clin Neuropharmacol. 2009 Nov-Dec;32(6):326-9. doi: 10.1097/WNF.0b013e3181b52792.

PMID:
19855268
2.

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y.

Mov Disord. 2009 Jun 15;24(8):1154-61. doi: 10.1002/mds.22496.

PMID:
19412954
3.

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

Linazasoro G, Van Blercom N, Ugedo L, Ruiz Ortega JA.

J Neural Transm (Vienna). 2008;115(3):431-41. doi: 10.1007/s00702-007-0852-z. Epub 2008 Feb 4. Review.

PMID:
18250954
4.

Prevalence of tic disorder in two schools in the Basque country: Results and methodological caveats.

Linazasoro G, Van Blercom N, de Zárate CO.

Mov Disord. 2006 Dec;21(12):2106-9.

PMID:
17013915
5.

[Treatment of Parkinson disease: therapeutic reserve of the dopaminergic agonist].

Linazasoro G, van Blercom N.

Neurologia. 2006 Sep;21(7):365-75. Review. Spanish.

PMID:
16977557
6.

Severe stuttering and motor tics responsive to cocaine.

Linazasoro G, Van Blercom N.

Parkinsonism Relat Disord. 2007 Feb;13(1):57-8. Epub 2006 Jul 5.

PMID:
16822697
7.

Three in one: case report supporting different origins of essential and parkinsonian tremors.

Linazasoro G, Van Blercom N, Magariños C.

Eur Neurol. 2006;55(2):108-9. Epub 2006 Apr 21. No abstract available.

8.

Efficacy and safety of donepezil in the treatment of executive dysfunction in Parkinson disease: a pilot study.

Linazasoro G, Lasa A, Van Blercom N.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):176-8.

PMID:
16062096
9.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
10.

The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.

Martínez-Martín P, Benito-León J, Burguera JA, Castro A, Linazasoro G, Martínez-Castrillo JC, Valldeoriola F, Vázquez A, Vivancos F, del Val J, van Blercom N, Frades B.

J Clin Epidemiol. 2005 Jul;58(7):674-9. Epub 2005 Apr 20.

PMID:
15939218
11.

Etiological and therapeutical observations in a case of belly dancer's dyskinesia.

Linazasoro G, Van Blercom N, Lasa A, Fernández JM, Aranzábal I.

Mov Disord. 2005 Feb;20(2):251-3.

PMID:
15455446
12.

Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.

Linazasoro G, Van Blercom N, Castro A, Dapena MD.

Neurology. 2004 Aug 10;63(3):589-90. No abstract available.

PMID:
15304607
13.

Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.

Van Blercom N, Lasa A, Verger K, Masramón X, Sastre VM, Linazasoro G.

Clin Neuropharmacol. 2004 May-Jun;27(3):124-8.

PMID:
15190235
14.

[Hypothesis: Parkinson's disease, reward deficiency syndrome and addictive effects of levodopa].

Linazaroso G, van Blercom N, Lasa A.

Neurologia. 2004 Apr;19(3):117-27. Review. Spanish.

PMID:
15088161
15.

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.

N Engl J Med. 2003 Nov 13;349(20):1925-34.

16.

Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease.

Linazasoro G, Van Blercom N, Lasa A.

Mov Disord. 2003 Jun;18(6):713-6.

PMID:
12784280
17.

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, Moro E, Benabid AL, Pollak P.

Mov Disord. 2003 May;18(5):524-30.

PMID:
12722166
18.

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

Lagrange E, Krack P, Moro E, Ardouin C, Van Blercom N, Chabardes S, Benabid AL, Pollak P.

Neurology. 2002 Dec 24;59(12):1976-8.

PMID:
12499496
19.

Predictors of effective bilateral subthalamic nucleus stimulation for PD.

Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G, Benabid AL, Pollak P.

Neurology. 2002 Sep 24;59(6):932-4.

PMID:
12297584
20.

Possible sporadic rapid-onset dystonia-parkinsonism.

Linazasoro G, Indakoetxea B, Ruiz J, Van Blercom N, Lasa A.

Mov Disord. 2002 May;17(3):608-9.

PMID:
12112218
21.

Levodopa-induced ocular dyskinesias in Parkinson's disease.

Linazasoro G, Van Blercom N, Lasa A, Indakoetxea B, Ruiz J.

Mov Disord. 2002 Jan;17(1):186-7.

PMID:
11835460
22.

[Surgical treatment of Parkinson disease: turning the tide?].

Linazasoro G, Van Blercom N, Ramos E.

Neurologia. 2002 Jan;17(1):1-6. Review. Spanish. No abstract available.

PMID:
11834191
23.

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. 2000.

Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, Benabid AL.

Neurology. 2001 Nov;57(10 Suppl 3):S60-2. No abstract available.

PMID:
11775603
24.

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease.

Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, Benabid AL.

Neurology. 2000 Dec 26;55(12):1921-3.

PMID:
11134399
25.

Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy.

Moro E, Esselink RA, Van Blercom N, Caputo E, Pollak P, Limousin P, Hariz MI.

Mov Disord. 2000 Jul;15(4):753-5. No abstract available.

PMID:
10928596
26.

Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease.

Limousin-Dowsey P, Pollak P, Van Blercom N, Krack P, Benazzouz A, Benabid A.

J Neurol. 1999 Sep;246 Suppl 2:II42-5. Review.

PMID:
10526001
27.

Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.

Dethy S, Van Blercom N, Damhaut P, Wikler D, Hildebrand J, Goldman S.

Mov Disord. 1998 Mar;13(2):275-80.

PMID:
9539341
28.

Dissociation in the neural control of single-joint and multi-joint movements in the thalamic ataxia syndrome.

van Blercom N, Manto M, Jacquy J, Hildebrand J.

J Neurol Sci. 1997 Oct 3;151(1):71-7.

PMID:
9335013
29.

Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients.

Dethy S, Laute MA, Van Blercom N, Damhaut P, Goldman S, Hildebrand J.

Clin Chem. 1997 May;43(5):740-4.

30.

[Cerebrovascular accidents of unusual etiology and fatal course].

Delplace J, Van Blercom N, Dargent JL, Blecic S, Jacobovitz D.

Ann Pathol. 1995;15(3):219-20. French. No abstract available.

PMID:
7639861

Supplemental Content

Loading ...
Support Center